PortfoliosLab logo

Teva Pharmaceutical Industries Limited

TEVA
Equity · Currency in USD
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
ISIN
US8816242098
CUSIP
881624209

TEVAPrice Chart


Chart placeholderClick Calculate to get results

TEVAPerformance

The chart shows the growth of $10,000 invested in Teva Pharmaceutical Industries Limited on Jan 5, 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $2,142 for a total return of roughly -78.58%. All prices are adjusted for splits and dividends.


TEVA (Teva Pharmaceutical Industries Limited)
Benchmark (S&P 500)

TEVAReturns in periods

Returns over 1 year are annualized

PeriodReturn
1M16.71%
6M-0.69%
YTD4.97%
1Y6.86%
5Y-24.84%
10Y-11.22%

TEVAMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

TEVASharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Teva Pharmaceutical Industries Limited Sharpe ratio is 0.18. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.

The chart below displays rolling 12-month Sharpe Ratio.


TEVA (Teva Pharmaceutical Industries Limited)
Benchmark (S&P 500)

TEVADividends

Teva Pharmaceutical Industries Limited granted a 0.00% dividend yield in the last twelve months, as of Oct 23, 2021. The annual payout for that period amounted to $0.00 per share.


PeriodTTM20202019201820172016201520142013201220112010
Dividend$0.00$0.00$0.00$0.00$0.85$1.36$1.36$1.37$1.28$1.03$0.90$0.75

Dividend yield

0.00%0.00%0.00%0.00%4.49%3.75%2.07%2.38%3.19%2.77%2.23%1.43%

TEVADrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


TEVA (Teva Pharmaceutical Industries Limited)
Benchmark (S&P 500)

TEVAWorst Drawdowns

The table below shows the maximum drawdowns of the Teva Pharmaceutical Industries Limited. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Teva Pharmaceutical Industries Limited is 90.80%, recorded on Aug 15, 2019. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-90.8%Jul 28, 20151021Aug 15, 2019
-43.97%Mar 24, 2010381Sep 23, 2011783Nov 4, 20141164
-11.77%Apr 10, 201555Jun 26, 201520Jul 27, 201575
-5.94%Nov 7, 201440Jan 6, 20159Jan 20, 201549
-5.88%Jan 26, 201511Feb 9, 201522Mar 12, 201533
-4.52%Jan 11, 201015Feb 1, 201014Feb 22, 201029
-2.79%Mar 8, 20108Mar 17, 20101Mar 18, 20109
-2.2%Mar 24, 20152Mar 25, 20156Apr 2, 20158
-1.8%Jan 5, 20103Jan 7, 20101Jan 8, 20104
-1.21%Mar 3, 20101Mar 3, 20101Mar 4, 20102

TEVAVolatility Chart

Current Teva Pharmaceutical Industries Limited volatility is 27.41%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


TEVA (Teva Pharmaceutical Industries Limited)
Benchmark (S&P 500)

Portfolios with Teva Pharmaceutical Industries Limited


Loading data...

More Tools for Teva Pharmaceutical Industries Limited